This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

RECTOGESIC-product-image

STEXEROL-D3

colecalciferol

Stexerol-D3 is indicated in adults, the elderly and adolescents for prevention and treatment of vitamin D deficiency, or as an adjunct to specific therapy for osteoporosis in patients with vitamin D deficiency or at risk of vitamin D insufficiency.1

Adverse Events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk/. Adverse Events should also be reported to Kyowa Kirin International UK NewCo Ltd, known as Grünenthal Meds on +44 (0)1896 664000, email PVUK@grunenthalmeds.com

Click here for prescribing information.

Certain people may be at greater risk of vitamin D insufficiency or deficiency. Patients who have low / no exposure to sunlight.2

Vitamin D is synthesised in the skin upon exposure to sunlight containing sufficient ultraviolet B (UVB) radiation and this is the main source for most people.2

Patients with dark skin tones.2

The pigment melanin, which gives skin its brown or black colour, absorbs UV radiation.2

Patients who are over 65.3

The metabolism of vitamin D and calcium becomes more complex with age. Older people have less 7-dehydrocholesterol, which reduces their capacity to produce vitamin D.3

Patients who are overweight.3

Vitamin D is stored in fat cells, but this source is not readily available as it cannot be released until the fat cells are broken down.3

Patients who are vegetarian or vegan.4

A study found that, in the UK, plasma 25(OH)D concentrations were lower in vegetarians and vegans than in meat and fish eaters.4

Average:

  • References

    1. Stexerol-D3 Tablets SPC.

    2. Scientific Advisory Committee on Nutrition (SACN), Vitamin D and Health Report, 2016.

    3. Bentley J. Vitamin D deficiency: identifying gaps in the evidence base. Nursing Standard. 2013;27,46,35-41.

    4. Spiro A and Buttriss JL. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr Bull. 2014;39(4):322–350.

    M-SD3-UK-11-23-0003 June 2024